The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment

A Emami Nejad, S Najafgholian, A Rostami… - Cancer Cell …, 2021 - Springer
Hypoxia is a common feature of solid tumors, and develops because of the rapid growth of
the tumor that outstrips the oxygen supply, and impaired blood flow due to the formation of …

Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection

RJ Reiter, R Sharma, F Simko… - Cellular and Molecular …, 2022 - Springer
Numerous pharmaceutical drugs have been repurposed for use as treatments for COVID-19
disease. These drugs have not consistently demonstrated high efficacy in preventing or …

[HTML][HTML] Hypoxia-mediated cancer stem cell resistance and targeted therapy

X Sun, X Lv, Y Yan, Y Zhao, R Ma, M He… - Biomedicine & …, 2020 - Elsevier
Drug resistance is a major obstacle in the treatment of tumors, which easily lead to relapse
or poor prognosis. Cancer stem cells (CSCs) are regarded as one of the important targets …

Use of melatonin in cancer treatment: where are we?

L Wang, C Wang, WS Choi - International Journal of Molecular Sciences, 2022 - mdpi.com
Cancer represents a large group of diseases accounting for nearly 10 million deaths each
year. Various treatment strategies, including surgical resection combined with …

Antitumor effect of melatonin on breast cancer in experimental models: A systematic review

PIR Franco, JR do Carmo Neto, AC Milhomem… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Breast cancer is the most frequent malignant neoplasm in females. While conventional
treatments such as chemotherapy and radiotherapy are available, they are highly invasive …

Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line

NF Maroufi, M Rashidi, V Vahedian, R Jahanbazi… - Breast Cancer, 2022 - Springer
Background and aim Vasculogenic mimicry (VM) is one of the most important causes of
breast cancer metastasis and resistance against drugs. The cancer stem cells (CSCs) are …

[HTML][HTML] MicroRNAs: important players in breast cancer angiogenesis and therapeutic targets

BM Hussen, ST Abdullah, MF Rasul, A Salihi… - Frontiers in molecular …, 2021 - frontiersin.org
The high incidence of breast cancer (BC) is linked to metastasis, facilitated by tumor
angiogenesis. MicroRNAs (miRNAs or miRs) are small non-coding RNA molecules that …

[HTML][HTML] Targeting cancer drug resistance utilizing organoid technology

C Chai, P Ji, H Xu, H Tang, Z Wang, H Zhang… - Biomedicine & …, 2023 - Elsevier
Cancer organoids generated from 3D in vitro cell cultures have contributed to the study of
drug resistance. Maintenance of genomic and transcriptomic similarity between organoids …

Cancer stem cell-targeted therapeutic approaches for overcoming trastuzumab resistance in HER2-positive breast cancer

Y Qiu, L Yang, H Liu, X Luo - Stem Cells, 2021 - academic.oup.com
Application of the anti-HER2 drug trastuzumab has significantly improved the prognosis of
patients with the HER2-positive subtype of breast cancer. However, 50% of patients with …

Far-reaching advances in the role of carbon nanotubes in cancer therapy

BF Dizaji, S Khoshbakht, A Farboudi, MH Azarbaijan… - Life Sciences, 2020 - Elsevier
Cancer includes a group of diseases involving unregulated cell growth with the potential to
invade or expand to other parts of the body, resulting in an estimate of 9.6 million deaths …